occipital horn syndrome ohs formerly considered variant xlinked recessive mitochondrial connective tissue disorder caused deficiency transport essential mineral copper associated mutations children ohs thought genetically inherited disorder disease family history since disorder xlinked recessive disease affects males second x chromosome unlike females essentially lacking backup copy proper function females much likely carriers female affected must carry two defective x chromosomes disorder considered milder variant menkes characterized deficiency biliary copper excretion causes deformations skeleton include projections back skull parasagittal bone exostoses arising occipital socalled occipital horns well deformities elbow radial head dislocation hammershaped lateral ends clavicles abnormalities hips ohs presents early middle children may present features ohs milder allelic variant menkes disease later age onset associated far less severe central neurodegeneration milder nature ohs often attributable leaky splice junction mutations allow messenger rna mrna transcripts correctly processed cases menkes disease individuals ohs manifest connective tissue abnormalities resulting deficient activity lysyl oxidase copperrequiring enzyme normally deaminates lysine hydroxylysine first step collagen crosslink formation individuals also often endure inconvenient dysautonomic signs symptoms related partial deficiency dopamineÎ²hydroxylase dbh activity dbh another copperdependent enzyme normally converts dopamine norepinephrine crucial neurotransmitter norepinephrinergic neurons natural mouse model ohs socalled mottled blotchy model recapitulates connective tissue abnormalities dbh deficiency mild cns damage seen initial diagnosis menkes disease md milder variants occipital horn syndrome based clinical symptoms low serum copper ceruloplasmin levels support clinical suspicion ohs biochemical confirmation tissue culture needed ultimate diagnostic proof demonstration molecular defect demonstration bony protuberances occiput clinch diagnosis palpated courses treatment children ohs dependent upon severity case children ohs often receive physical occupational may require feeding tube supplement nourishment growing enough attempt improve neurological condition seizures copper histidine copper chloride injections given early childs life however copper histidine injections shown ineffective treating connective tissue manifestations long term natural history ohs patients died suddenly young years whereas one patient survived age causes death include respiratory aortic intracranial nih cyprium therapeutics coordinating jointdevelopment adenoassociated virus gene therapy named menkes disease milder variants occipital horn march cyprium therapeutics acquired worldwide development commercial rights menkes program nihnichd crada licensing agreements still preclinical stage although received orphan drug designation fdacitation needed httpsenwikipediaorgwikioccipitalhornsyndrome